November 2008 Issue of MMM

November 2008 Issue of MMM

November 2008

Editor's Desk

Never mind the ballots

Chances are that by the time you read this column the dust will already have settled on the voting machines and the identity of the ...

Features

Sales Force Report: Loop of Faith

The traditional sales force model is undergoing a metamorphosis. Anthony Vecchione reports on how pharma companies are investing heavily in closed-loop marketing as they look ...

How to work together

Over one-third of new pharma products are developed through strategic alliances. It is essential to learn to function productively within them. Deborah Dick-Rath offers some ...

The anatomy of an email

Email is one of the most effective ways to drive traffic and get your preferred marketing message across. Terry Nugent looks at what attributes help ...

Specialty Spiral

It was a dismal six months for specialty journals with only optometry posting a marginal gain in ad spend; the other seven sectors registered losses. ...

Headliner: Merz North America's Jack Britts

On September 2, Jack Britts was named president & CEO of Merz Pharmaceuticals, the North American subsidiary of privately held German firm Merz GmbH & ...

Vantage Point

Vantage Point

As we have discussed in this column from several different perspectives, pharma marketing research is going through major transitions.

Antidote

Antidote

I have nothing against generic medications.

In Focus

Lilly deal could set the bar for disclosures

Eli Lilly & Co.'s $62 million settlement with 32 states and the District of Columbia over off-label Zyprexa marketing comes with a stringent agreement requiring, ...

Med Ed Report

Merck, Lilly unveil disclosure policies

Merck announced plans to disclose some grants made by its global human health division for independent educational initiatives in the US, including those for accredited ...

Partner Forum

Web 2.0: The fine line between old and new

With all the buzz over Web 2.0 and social media, are pharma marketers losing sight of interactive fundamentals like SEO and old-fashioned banner ads? Is ...

Direct Marketing

BDA helps reps navigate PhRMA regs

In anticipation of the new PhRMA guidelines that go into effect in January 2009, drug companies are scrambling to find innovative ways to deliver pharma ...

Free samples don't target poor kids

A study published in the October 2008 edition of the journal Pediatrics concluded that poor and uninsured children are not the main recipients of free ...

Merck inks rep deal with inVentiv

In a strategic partnership with inVentiv, Merck announced that it will utilize inVentiv's contract sales staff to supplement Merck's in-house sales force.

DTC Report

DDMAC warns Bayer on YAZ TV ads

The FDA slapped Bayer HealthCare Pharmaceuticals with a warning letter on two 60-second TV ads for its YAZ contraceptive.

Kohl seeks backup for device ads

Sen. Herb Kohl (D-WI) said DTC ads for devices should be regulated just as much as those for drugs and called on his colleague in ...

Digital Media

Reuters Health joins The Doctor's Channel

The Doctor's Channel, an online provider of streaming medical videos, has partnered with Reuters Health.

Online detailing taking off: study

According to the results of a new study, about 45,000 US physicians meet with sales reps via online video, and more than 300,000 have shown ...

Web Watch

Marjorie Martin, SVP and general manager of Everyday Health, believes consumers will be the big winner in the merger of Revolution Health and Everyday Health.

Public Relations

PR View by Maryellen Royle

As a company that focuses on healthcare PR, we are often involved in early-stage product communications.

Johnson & Johnson reorganizes its PR team

Johnson & Johnson (J&J) has announced a restructuring of its public affairs and corporate communications team.

Porter Novelli partnering with CMS

Porter Novelli's Washington, DC, office landed a multimillion dollar contract from the Centers for Medicare and Medicaid Services (CMS).

Marketing Research

FDA database aims to limit Rx name mix-ups

FDA will initiate a pilot project to help manufacturers choose safe proprietary drug names.

SK&A launches doc verification tool

Each year, up to 18 % of doctors move, retire, pass away or make other professional changes.

Washington Insider

As I see it

Add to all the other Washington unravelings of the past nine years the loss of FDA innocence.

Back Talk

Pens and doughnuts

Disclosure: My father and mother were both physicians so I obviously have a pro-doctor bias.


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters